Founded in 2017, Morphle Labs operates in Health Tech offering innovative automation solutions for the cancer diagnostics industry. The company focuses on developing advanced products such as Robotome...
Funding stage:
Series A
Last funding:
24/11/2025
Total funding:
$5.00 Mn+
Revenue:
Investors
Employee count:
105
Last 90d
105
Last 90d
Web traffic:
6.07K
6.07K
Last 30d
Last 30d
Morphle Labs: Cap Table Highlights
A snapshot of cap table and shareholder metrics
Total Shareholders3
Latest Filing Date24 Sept 2025- Funding Events11
Event-Based View
Event-Based detailed View by Filings
FAQs on Cap Table of Morphle Labs
As of 25 September 2025, Morphle Labs's equity is held by 3 shareholders, with the top three being Morphle, Inflexor Technology Fund, and Rohit Hiwale.
Morphle holds the largest stake in Morphle Labs at 92.4% as of 25 September 2025.
As of 25 September 2025, founders collectively hold 0.0% equity in Morphle Labs.
As of 25 September 2025, investors collectively hold 7.6% equity in Morphle Labs.
Disclaimer
Inc42 Datalabs consolidates intelligence from public records, statutory filings, proprietary research, and vetted third‑party datasets. All information is provided as is—please run your own checks before acting on it. Inc42 Datalabs bears no responsibility for decisions or outcomes based on this data.
Quick Links